Lung cancer in patients who have never smoked—an emerging disease

J LoPiccolo, A Gusev, DC Christiani… - Nature Reviews Clinical …, 2024 - nature.com
Lung cancer is the most common cause of cancer-related deaths globally. Although smoking-
related lung cancers continue to account for the majority of diagnoses, smoking rates have …

[HTML][HTML] The promise of artificial intelligence and deep learning in PET and SPECT imaging

H Arabi, A AkhavanAllaf, A Sanaat, I Shiri, H Zaidi - Physica Medica, 2021 - Elsevier
This review sets out to discuss the foremost applications of artificial intelligence (AI),
particularly deep learning (DL) algorithms, in single-photon emission computed tomography …

Deep learning with radiomics for disease diagnosis and treatment: challenges and potential

X Zhang, Y Zhang, G Zhang, X Qiu, W Tan, X Yin… - Frontiers in …, 2022 - frontiersin.org
The high-throughput extraction of quantitative imaging features from medical images for the
purpose of radiomic analysis, ie, radiomics in a broad sense, is a rapidly develo** and …

Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration

L Wei, D Niraula, EDH Gates, J Fu, Y Luo… - The British Journal of …, 2023 - academic.oup.com
Multiomics data including imaging radiomics and various types of molecular biomarkers
have been increasingly investigated for better diagnosis and therapy in the era of precision …

[HTML][HTML] Machine learning-based radiomics signatures for EGFR and KRAS mutations prediction in non-small-cell lung cancer

NQK Le, QH Kha, VH Nguyen, YC Chen… - International journal of …, 2021 - mdpi.com
Early identification of epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral
oncogene homolog (KRAS) mutations is crucial for selecting a therapeutic strategy for …

Predicting EGFR mutation status in non–small cell lung cancer using artificial intelligence: a systematic review and meta-analysis

HS Nguyen, DKN Ho, NN Nguyen, HM Tran… - Academic …, 2024 - Elsevier
Rationale and Objectives Recent advancements in artificial intelligence (AI) render a
substantial promise for epidermal growth factor receptor (EGFR) mutation status prediction …

Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer

X Yin, H Liao, H Yun, N Lin, S Li, Y **ang… - Seminars in cancer biology, 2022 - Elsevier
Lung cancer accounts for the main proportion of malignancy-related deaths and most
patients are diagnosed at an advanced stage. Immunotherapy and targeted therapy have …

[HTML][HTML] Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients

I Shiri, M Sorouri, P Geramifar, M Nazari… - Computers in biology …, 2021 - Elsevier
Objective To develop prognostic models for survival (alive or deceased status) prediction of
COVID-19 patients using clinical data (demographics and history, laboratory tests, visual …

A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis

F Khatami, M Saatchi, SST Zadeh, ZS Aghamir… - Scientific reports, 2020 - nature.com
Nowadays there is an ongoing acute respiratory outbreak caused by the novel highly
contagious coronavirus (COVID-19). The diagnostic protocol is based on quantitative …

From understanding diseases to drug design: can artificial intelligence bridge the gap?

AC Pushkaran, AA Arabi - Artificial Intelligence Review, 2024 - Springer
Artificial intelligence (AI) has emerged as a transformative technology with significant
potential to revolutionize disease understanding and drug design in healthcare. AI serves as …